Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Phenylephrin + Dimetinden

Generic name
Phenylephrin + Dimetinden
Brand name
ATC Code
R01AB01

Pharmacokinetics in children

Keine Information

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Acute rhinitis, acute exacerbation of chronic, allergic and vasomotor rhinitis, adjuvant for sinusitis
  • Nasal
    • 2 years up to 6 years
      • Drops 2.5 mg (phenylephrine) + 0.25 mg (dimetinden) / ml:
        1 - 2 drops in each nostril 3-4 times daily.

         

        • There should be at least 6 hours between 2 applications.
        • Do not use for longer than 7 days, unless prescribed by a doctor.

         

    • 6 years up to 12 years
      • Drops or spray 2.5 mg (phenylephrine) + 0.25 mg (dimetinden) / ml:
        1 - 2 drops or 1 spray in each nostril 3 -4 times daily

        • There should be at least 6 hours between 2 applications.
        • Do not use for longer than 7 days, unless prescribed by a doctor.
    • 12 years up to 18 years
      • Drops or spray 2,5 mg (Phenylephrin) + 0,25 mg (Dimetinden)/ml:
         
        2 - 3 drops or 2 sprays in each nostril 3 - 4 times daily

        • There should be at least 6 hours between 2 applications.
        • Do not use for longer than 7 days, unless prescribed by a doctor.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

References

  1. GlaxoSmithKline-Gebro, SmPC Vibrocil Nasenspray (1-19041), https://aspregister.basg.gv.at/, aufgerufen am 27.01.2021
  2. GlaxoSmithKline-Gebro, SmPC Vibrocil Nasentropfen (1-18035), https://aspregister.basg.gv.at/, aufgerufen am 27.01.2021

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes